Anteris Technologies Global (NASDAQ:AVR) Major Shareholder L1 Capital Pty Ltd Sells 14,581 Shares

Anteris Technologies Global Corp. (NASDAQ:AVR) major shareholder L1 Capital Pty Ltd sold 14,581 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The shares were sold at an average price of $8.23, for a total transaction of $120,001.63. Following the sale, the insider directly owned 5,613,721 shares of the company’s stock, valued at $46,200,923.83. This trade represents a 0.26% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their transactions with the SEC.

L1 Capital Pty Ltd also recently made the following trade(s):

• On Tuesday, August 4th, L1 Capital Pty Ltd sold 480,608 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.30, for a total value of $3,989,046.40.
• On Monday, August 3rd, L1 Capital Pty Ltd sold 475,693 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.10, for a total value of $3,853,113.30.
• On Friday, July 31st, L1 Capital Pty Ltd sold 48,711 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.15, for a total value of $396,994.65.
• On Wednesday, July 29th, L1 Capital Pty Ltd sold 155,505 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.04, for a total value of $1,250,260.20.
• On Thursday, July 30th, L1 Capital Pty Ltd sold 558,633 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.20, for a total value of $4,580,790.60.
• On Monday, July 27th, L1 Capital Pty Ltd sold 232,817 shares of Anteris Technologies Global stock. The stock was sold at an average price of $8.19, for a total value of $1,906,771.23.
• On Tuesday, July 28th, L1 Capital Pty Ltd sold 208,731 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.09, for a total transaction of $1,688,633.79.
• On Friday, July 24th, L1 Capital Pty Ltd sold 23,000 shares of Anteris Technologies Global stock. The shares were sold at an average price of $8.13, for a total transaction of $186,990.00.

Anteris Technologies Global Stock Up 3.9%

Shares of AVR stock opened at $8.36 on Friday. The company has a 50 day moving average price of $9.15 and a 200-day moving average price of $7.26. Anteris Technologies Global Corp. has a 52 week low of $3.17 and a 52 week high of $11.06. The firm has a market capitalization of $813.78 million, a PE ratio of -3.75 and a beta of 1.78.

Anteris Technologies Global (NASDAQ:AVR) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The company had revenue of $0.49 million for the quarter, compared to the consensus estimate of $0.77 million. During the same quarter last year, the company earned ($0.61) EPS. Analysts anticipate that Anteris Technologies Global Corp. will post -1.14 earnings per share for the current year.

Institutional Trading of Anteris Technologies Global

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in AVR. Persistent Asset Partners Ltd bought a new position in Anteris Technologies Global in the second quarter worth approximately $413,000. Bank of New York Mellon Corp purchased a new stake in shares of Anteris Technologies Global in the 2nd quarter worth $2,292,000. Walleye Capital LLC bought a new position in Anteris Technologies Global in the 2nd quarter worth $536,000. Assenagon Asset Management S.A. purchased a new position in Anteris Technologies Global during the second quarter valued at $6,350,000. Finally, Militia Capital Management LLC bought a new stake in Anteris Technologies Global during the first quarter valued at about $3,663,000.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Barclays increased their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the company an “overweight” rating in a report on Friday, May 15th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Finally, Wall Street Zen raised Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $16.00.

About Anteris Technologies Global

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.